Skip Navigation LinksHome > August 2014 - Volume 33 - Issue 8 > Safety and Tolerability of High-dose Weekly Liposomal Amphot...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000335
Antimicrobial Reports

Safety and Tolerability of High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis

Hand, Elizabeth O. PharmD, BCPS*†‡; Ramanathan, Meenakshi R. PharmD*†§

Collapse Box


Children with hematologic malignancies are at an increased risk of invasive fungal infections and a greater risk has been seen with exposure to building construction. Prophylaxis with high-dose (IV) liposomal amphotericin B (L-AmB) 10 mg/kg once weekly was initiated in our high risk children based on previous pharmacokinetic studies. This treatment regimen was associated with a 26% incidence of adverse infusion reactions.

© 2014 by Lippincott Williams & Wilkins, Inc.


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.